- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 204.33M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.13B |
| Long Term Debt restated | Q1 2025 · Mar 31, 2024 | $2.19B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $66.9M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $72.72M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $678.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $922.82M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $666.26M |
| Current Assets | Q1 2025 · Mar 31, 2024 | $1.32B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.04B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $7.84B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 204.19M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $25.9M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $116.99M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $165.1M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.98B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.91B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.49 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.50 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $107.61M |
| Net Income | Q1 2025 · Mar 31, 2024 | $100.9M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $96.66M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $588.2M |